Equities

Dolby Laboratories Inc

Dolby Laboratories Inc

Actions
TechnologyTechnology
  • Price (EUR)75.00
  • Today's Change2.00 / 2.74%
  • Shares traded10.00
  • 1 Year change-0.92%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The Company's products are used in content creation, distribution and playback to enhance image and sound quality and improve transmission and playback. Its cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. The Company's other products include three dimensional glasses and kits, broadcast hardware and software. Its technology includes Dolby Atmos, Dolby TrueHD, Dolby Vision and Dolby Digital Plus.

  • Revenue in USD (TTM)1.28bn
  • Net income in USD188.26m
  • Incorporated2004
  • Employees2.25k
  • Location
    Dolby Laboratories Inc1275 Market StreetSAN FRANCISCO 94103United StatesUSA
  • Phone+1 (415) 558-0200
  • Fax+1 (415) 645-4000
  • Websitehttps://www.dolby.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.